logo

ENTERO vs MEESHO: Stock Comparison

ENTERO HEALTHCARE SOLU L vs MEESHOUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

MEESHO is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows faster revenue growth and a higher net margin, while MEESHO shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ENTERO leads 5; MEESHO leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ENTEROMEESHO

Valuation lens

What price are you paying?

Market CapContext only
₹6,558 Cr
₹1.04 L Cr
P/E RatioMEESHO has the lower reading
52.28x
0x ✓
P/B RatioENTERO has the lower reading
3.88x ✓
23.49x
EPSENTERO has the higher reading
₹8.77 ✓
₹-0.29
Book ValueContext only
₹402.67
₹9.52
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MEESHO is the larger company
₹1.04 L Cr vs ₹6,558 Cr
P/E Ratio
MEESHO has a lower P/E
0x vs 52.28x
P/B Ratio
ENTERO has a lower P/B
3.88x vs 23.49x
EPS
ENTERO has higher earnings per share
₹8.77 vs ₹-0.29
Revenue Growth (TTM YoY)
ENTERO has faster revenue growth
42.6% vs 0%
EPS Growth (TTM YoY)
ENTERO has faster EPS growth
9.1% vs 0%
ROE
MEESHO has a higher ROE
82.44% vs 1.6%
ROCE
MEESHO has a higher ROCE
83.41% vs 2.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricENTEROMEESHO
SectorConsumer Services—
IndustryPharmacy Retail—

Price

MetricENTEROMEESHO
Live Price₹1,503.9₹229.59
Day Change-5.12%1.05%
Volume1.65 L69.64 L
52-Week High₹1,920₹254.4
52-Week Low₹944₹125.56
Distance from 52W High-21.67%-9.75%

Valuation

MetricENTEROMEESHO
Market Cap₹6,558 Cr₹1.04 L Cr
P/E Ratio52.28x0x
P/B Ratio3.88x23.49x
EPS₹8.77₹-0.29
Book Value₹402.67₹9.52
Dividend Yield0%0%

Growth

MetricENTEROMEESHO
Revenue Growth (TTM YoY)42.6%0%
EPS Growth (TTM YoY)9.1%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricENTEROMEESHO
ROE1.6%82.44%
ROCE2.01%83.41%
Net Margin1.75%-10.75%
Operating Margin9.99%430.79%
Debt to Equity0.06x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricENTEROMEESHO
Promoter Holding14.4%▼ 0.01 pp16.34%▼ 0.07 pp
FII Holding4.37%▲ 0.34 pp9.83%▲ 4.64 pp
DII Holding15.48%▼ 1.14 pp13.66%▲ 4.52 pp
Public Holding27.75%▲ 0.82 pp60.17%▼ 9.09 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and MEESHO.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.